BIVI BIVI
Company Profile ↓Company Overview
BIVI (BIVI) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Net profit has compounded at 10.9% per year over the last five years.
Carries low leverage with a debt-to-equity ratio of 0.02.
Recent Developments
- 5-Year Trend Long-term compounding — profit CAGR 10.9%.
Growth & Price Performance
Compounded Profit Growth
| 5 Years: | 10.92% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -66.00% |
| 6 Months: | +71.43% |
| 3 Months: | +23.64% |
| 1 Month: | -5.56% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)62.31 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Profit CAGR of 10.9% over 5 years.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading 66.0% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Sep 2014 | Dec 2014 | Mar 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | 0 | - | - | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income | - | - | - | - | - | - | - | -54.63K | -49.93K | -57.85K | -351.35K | -357.80K | -400.53K | -662.23K | -494.81K | -691.22K | -491.43K | -500.87K | -848.29K | -706.22K | -710.45K | -699.25K | -386.75K | -3.06M | -3.00M | -5.55M | -6.67M | -5.75M | -8.83M | -11.49M | -13.77M | -10.88M | -8.78M | -7.73M | -4.12M | -7.29M | -2.99M | -5.28M | -6.26M | -5.39M |
| Net Income | -17.51K | -53.49K | -47.13K | -48.04K | -58.78K | -70.48K | -48.95K | -54.57K | -49.88K | -57.81K | -351.34K | -357.80K | -178.50K | -662.84K | -502.68K | -692.56K | - | - | - | -3.82M | 6.67M | -366.40K | 7.33M | -3.06M | -2.99M | -5.54M | -5.41M | -7.04M | -10.42M | -15.69M | -15.04M | -10.71M | -8.40M | -8.07M | -4.15M | -7.11M | -2.79M | -5.09M | -6.07M | -5.27M |
| Diluted EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.20 | -0.34 | -5.06 | 1.29 | -0.07 | -7.75 | -0.22 | -0.22 | -0.23 | -0.22 | -0.28 | -0.38 | -0.50 | -0.43 | -2.92 | -2.20 | -2.00 | -7.00 | -4.55 | -1.51 | -0.98 | -0.77 | -0.70 |
| R&D Expense | - | 11.42K | 19.15K | 19.41K | 3.40K | - | - | 0 | - | - | 127.27K | 128.56K | 120.04K | 41.85K | 186.84K | 46.42K | 194.52K | 206.02K | 331.83K | 341.50K | 346.51K | 353.20K | 100.91K | 938.10K | 789.58K | 3.09M | 4.71M | 3.58M | 6.77M | 7.03M | 11.20M | 8.88M | 6.47M | 5.70M | 1.99M | 4.70M | 1.34M | 2.94M | 4.27M | 3.18M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | - | - | - | - | 27.25M | 45.08M | 32.18M | 18.07M |
| Operating Income | - | - | -233.38K | -432.03K | -1.55M | -2.37M | -2.50M | -2.69M | -138.05M | -27.25M | -45.08M | -32.18M | -18.07M |
| EBITDA | - | - | - | - | - | - | - | - | - | -23.69M | -45.73M | -29.00M | -16.98M |
| Interest Expense | - | - | - | - | - | - | - | - | - | 2.16M | 4.30M | 2.89M | 332.72K |
| Pretax Income | - | - | - | - | - | - | - | - | - | -26.08M | -50.26M | -32.12M | -17.54M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income | -17.51K | -321.90K | -233.01K | -431.92K | -1.33M | -2.43M | - | -16.68M | -130.25M | -26.08M | -50.26M | -32.12M | -17.54M |
| Diluted EPS | - | - | - | - | - | - | -0.98 | -6.85 | -14.82 | -106.00 | -154.70 | -73.05 | -12.12 |
| R&D Expense | - | 49.42K | 4.20K | 37.90K | 466.35K | 370.85K | 1.01M | 1.15M | 2.54M | 17.26M | 33.30M | 23.10M | 9.27M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 505.70K | 332.86K | 269.48K | 2.72M | 2.36M | 2.18M | 2.57M | 2.08M | 6.05M | 20.11M | 35.10M | 25.21M | 21.56M |
| Total Equity | 490.70K | 171.39K | -54.12K | 1.92M | 1.16M | 111.20K | 2.13M | -21.50M | 5.05M | 3.67M | 15.34M | 15.51M | 19.01M |
| Cash & Equivalents | - | - | - | - | - | - | - | - | - | 18.64M | 19.46M | 23.84M | 17.54M |
| Long Term Debt | - | - | - | - | - | - | - | 62.50K | - | - | - | - | - |
| Total Liabilities | - | - | - | 803.25K | 1.21M | 2.06M | 443.48K | 23.58M | 996.37K | 16.44M | 19.76M | 9.70M | 2.55M |
| Current Liabilities | 15.00K | 161.47K | 323.60K | 803.25K | 630.97K | 1.24M | 443.48K | 23.52M | 996.37K | 4.17M | 14.49M | 9.35M | 2.27M |
Cash Flows (Annual)
Figures in USD.
| Metric | Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.51K | -172.83K | -65.38K | -153.63K | -623.62K | -621.34K | -2.50M | -1.63M | -10.45M | -18.99M | -40.25M | -27.95M | -19.03M |
| Investing Cash Flow | - | - | - | 9.91K | - | - | - | - | - | - | -14.30M | 14.53M | - |
| Financing Cash Flow | 508.21K | - | - | -5 | 505.00K | 662.00K | 2.80M | 1.33M | 14.93M | 33.12M | 55.37M | 17.80M | 12.73M |
Ratios (Annual)
Figures in %.
| Metric | Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - |
| ROE % | -3.6% | -187.8% | 430.5% | -22.5% | -115.0% | -2,189.0% | - | 77.6% | -2,579.0% | -710.6% | -327.6% | -207.1% | -92.3% |
| ROCE % | - | - | 431.2% | -22.5% | -89.6% | -253.1% | -117.2% | 12.6% | -2,733.6% | -170.9% | -218.7% | -202.9% | -93.7% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for BIVI
BIVI Forecast — Price Target — Prediction for 2027 - TradingView
<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTE5MeDhRNEZySmNxTk1tT21zWU9hYnRVVGJlZUFHZW05V1lPOEs2elVyMDRlNDZUeWRqc2dGMDdZVC1ETVItSzVHOUJvSHhpWVdQVlBrOUx2ODZrRXZtdUNrRy1hWHdsS3J1ZnM3RUdVb1JQSWFCSzJMLU1n?oc=5" target="_blank">BIV…
BIOVIE ($BIVI) Releases Q3 2026 Earnings | BIVI Stock News - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMifkFVX3lxTE1qOTRqa3FzZHZWUi16UVRfc3JWM043RVYtSHFjZVdFcl9pZEdUSWxHSDZDcElMeklWWGdraTJhd2R5OFdmRlZBRFNsdk9xeXh6eVhMOXFTWkQyZHlNZUFjSm0xVjZMTmpLYU83OVN5bkFSU1FVSFZ0ajF5SDFkdw?oc=5" target="_blan…
[S-1/A] BIOVIE INC. Amends IPO Registration Statement - Stock Titan
<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxOZEdDNC1oc0V0WTZfbldaZnlXYWFaTlRJbmJ2RWQyRTM5YnNmRy1YMm4yd0w2Qmc2aEl6WnVmVzA2RHlNbXU4SkpCcWkwcDZjTW5qWEJqblZ3SE9GSk5WY3QxbkMwbGs2VFpoSVFIemJQcEtMUVN0dXJRakJaQ0FjejBUZDN2RjZ4Y3VFWk…
BIVI|BioVie Inc|Price:1.840|Chg%:+0.220 - TradingKey
<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE5lR2l0QTV5bmJ0U2dxM1JDeDNlbFlrNmdtN1FCMUN5eHk4Nzljb0xjUzNzemhQUmMzc2o2LXhoMnhobDZrTHRXZXQ1REN1ell0S3NCVEg2WDNVMGFuMmNyUGdxY18zeDU4WjhMbGpR?oc=5" target="_blank">BIVI|BioVie Inc|Pri…
Did BioVie Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PR Newswire
<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxPaU1tOWNGckg4UFlYcWs4V2VRQTdFMllrWGphRzZzMmtGbjU1ODJ3RTVpdGFid2xGMFg0UlhGMlBiRC1tN2o2YWQ3QUJTaFVlUDRBRXVYSmpXWk9mUXlEdm5OdXE5R0dSY04tSXozNUh3VmlXUGNfamx1VFl6WkRyYy05Z3huNjVRNjdDa2…
Should I buy BioVie (BIVI) - Zacks Investment Research
<a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE5QcTlhZ0FNb3V4aVVHUWU4X3pMUVhHaldreW5tcG5lQ3JBbnd3UFBsY1BFNTFvX1JsMENnakF0OW4yYXRUX0x3QlVjcWxEdjJRNEdUd0FDVTFxcUNiYTRxV2F0Z3VWSDlpT3lOQQ?oc=5" target="_blank">Should I buy BioVie (…
BIVI — Frequently Asked Questions
What is the current share price of BIVI?
As of 2026-08-05 17:25 PDT, BIVI trades at $2.04 on NASDAQ/NYSE. Its 52-week range is $1.06 to $6.00.
What is the P/E ratio of BIVI?
BIVI trades at a trailing price-to-earnings (P/E) ratio of -0.17.
What is the return on equity (ROE) of BIVI?
BIVI has a return on equity (ROE) of -92.27%. Its return on capital employed (ROCE) is -93.67%.
Is BIVI a good stock to buy?
This page provides a data-driven analysis of BIVI, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.